Urologix, Inc.
ULGX · OTC
6/30/2014 | 6/30/2013 | 6/30/2012 | 6/30/2011 | |
|---|---|---|---|---|
| Market Cap | $4 | $7 | $11 | $14 |
| - Cash | $1 | $2 | $2 | $3 |
| + Debt | $5 | $5 | $0 | $0 |
| Enterprise Value | $8 | $10 | $9 | $11 |
| Revenue | $14 | $17 | $17 | $13 |
| % Growth | -14.2% | -2.6% | 35.4% | – |
| Gross Profit | $6 | $8 | $8 | $7 |
| % Margin | 42.8% | 49.3% | 49.2% | 52% |
| EBITDA | -$6 | -$3 | -$3 | -$3 |
| % Margin | -44.6% | -18.4% | -20.3% | -25.1% |
| Net Income | -$8 | -$4 | -$5 | -$4 |
| % Margin | -53.4% | -25.9% | -27.6% | -29.7% |
| EPS Diluted | -0.36 | -0.21 | -0.32 | -0.26 |
| % Growth | -71.4% | 34.4% | -23.1% | – |
| Operating Cash Flow | -$2 | -$2 | -$1 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2 | -$2 | -$1 | -$3 |